实验研究
ENGLISH ABSTRACT
水溶性石墨烯基伊曲康唑滴眼液的制备及其抗真菌活性
李景果
韩奉奇
赵孟阳
何继军
梁珍
张俊杰
作者及单位信息
·
DOI: 10.3760/cma.j.cn115989-20230428-00153
Preparation and antifungal activity of water-soluble graphene-based itraconazole antifungal eye drops
Li Jingguo
Han Fengqi
Zhao Mengyang
He Jijun
Liang Zhen
Zhang Junjie
Authors Info & Affiliations
Li Jingguo
Department of Ophthalmology, Henan Province People's Hospital, Henan Eye Hospital, Zhengzhou 450003, China
Han Fengqi
Department of Ophthalmology, Henan Province People's Hospital, Henan Eye Hospital, Zhengzhou 450003, China
Zhao Mengyang
Department of Ophthalmology, Henan Province People's Hospital, Henan Eye Hospital, Zhengzhou 450003, China
He Jijun
Department of Ophthalmology, Henan Province People's Hospital, Henan Eye Hospital, Zhengzhou 450003, China
Liang Zhen
Department of Ophthalmology, Henan Province People's Hospital, Henan Eye Hospital, Zhengzhou 450003, China
Zhang Junjie
Department of Ophthalmology, Henan Province People's Hospital, Henan Eye Hospital, Zhengzhou 450003, China
·
DOI: 10.3760/cma.j.cn115989-20230428-00153
0
0
0
0
0
0
PDF下载
APP内阅读
摘要

目的制备水溶性石墨烯基伊曲康唑滴眼液并评估其抗腐皮镰刀菌活性。

方法通过对石墨烯进行氧化改性和高分子材料的修饰策略,制备出水溶性的聚乙二醇修饰石墨烯(GO-PEG)复合材料。通过扫描电子显微镜、表面电位和拉曼光谱等手段对复合材料进行表征。采用溶剂挥发法实现水溶性GO-PEG载体材料对伊曲康唑的负载,获得伊曲康唑滴眼液。采用紫外-可见分光光度计测量伊曲康唑滴眼液的药物负载量;采用微量稀释法和光学显微镜评估伊曲康唑滴眼液的体外抗腐皮镰刀菌效果。

结果扫描电子显微镜显示GO-PEG呈二维纳米薄片结构,拥有较多褶皱;表面电位分析显示GO-PEG的表面电位为-42.40 mV;拉曼光谱显示GO-PEG的ID/IG为1.003。水溶性GO-PEG载体负载最大的伊曲康唑药物质量浓度为10 mg/ml,相比于伊曲康唑的水溶解度(0.001 mg/ml),表观溶解度提高了10 000倍。伊曲康唑滴眼液对腐皮镰刀菌的最低抑菌质量浓度约为1.88 μg/ml,载体材料GO-PEG对腐皮镰刀菌无明显抗菌活性。

结论GO-PEG实现了对伊曲康唑的有效负载和增溶,表现出对体外腐皮镰刀菌的抑制作用。

抗真菌药物;伊曲康唑;溶解性;真菌性角膜炎;抗真菌性能
ABSTRACT

ObjectiveTo prepare water-soluble graphene-based itraconazole antifungal eye drops and evaluate its antifungal activity against Fusarium solani.

MethodsBy oxidative modification of graphene and modification of polymer materials, water-soluble graphene oxide-modified polyethylene glycol (GO-PEG) composites were prepared.The composites were characterized by scanning electron microscopy, zeta potential, and Raman spectroscopy.The antifungal drug itraconazole was loaded onto the GO-PEG vector by solvent evaporation method, and itraconazole eye drops were obtained.The drug loading of itraconazole eye drops was measured using a UV and visible spectrophotometer.The antifungal effectin vitro was assessed by the microdilution method and light microscopy.

ResultsScanning electron microscopy showed that GO-PEG had a two-dimensional nanosheet structure and many wrinkles.The zeta potential of GO-PEG was -42.40 mV.Raman spectroscopy showed that the ID/IG of GO-PEG was 1.003.Using the water-soluble GO-PEG vector, a maximum itraconazole concentration of 10 mg/ml was achieved with a 10 000-fold increase in apparent solubility (10 mg/ml vs 0.001 mg/ml). The antifungal results showed that the minimum inhibitory concentration of itraconazole eye drops against Fusarium solani was approximately 1.88 μg/ml, but the GO-PEG vector has no significant antifungal activity against Fusarium solani.

ConclusionsGO-PEG achieves effective loading and solubilization of itraconazole, demonstrating an in vitro inhibitory effect on Fusarium solani.

Antifungal agents;Itraconazole;Solubility;Fungal keratitis;Antifungal properties
Zhang Junjie, Email: mocdef.6ab2166jjgnahz
引用本文

李景果,韩奉奇,赵孟阳,等. 水溶性石墨烯基伊曲康唑滴眼液的制备及其抗真菌活性[J]. 中华实验眼科杂志,2023,41(07):641-645.

DOI:10.3760/cma.j.cn115989-20230428-00153

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
真菌性角膜炎是一种由致病真菌引起的致盲率较高的感染性眼病[ 1 ]。然而,其临床治疗受到眼部固有屏障和药物剂型短缺的限制[ 2 ],面临着可用抗真菌药物种类极少的问题。传统的三唑类广谱抗真菌药物伊曲康唑在预防侵袭性真菌感染和复发方面非常有效[ 3 ]。临床证实伊曲康唑对多种致病真菌菌属感染的治疗效果显著,主要包括曲霉菌、隐球菌、腐皮镰刀菌、念珠菌、囊胚菌、青霉菌等[ 4 , 5 ]。伊曲康唑主要抑制细胞色素P450氧化酶介导的麦角甾醇合成,从而影响真菌细胞壁的通透性来发挥抗真菌作用[ 6 ]。目前市售的伊曲康唑主要是全身应用的剂型,包括胶囊、口服液和注射液,且全身用药容易造成较严重的肝肾毒性[ 7 ]。伊曲康唑难溶于水,其在水(pH=7.4)中的溶解度仅为1.0 μg/ml,但其对于临床常见镰刀菌属的最小抑菌质量浓度为17.290 μg/ml[ 8 ],目前尚缺乏适用于眼科局部用药的相关伊曲康唑剂型。随着纳米技术的发展,目前已有相关纳米剂型提高药物溶解度的报道,如纳米微乳、纳米颗粒、固体脂质体、有机高分子材料修饰等[ 2 , 7 , 8 ],但采用新型二维材料负载伊曲康唑的研究较少见。石墨烯材料作为21世纪备受瞩目的新材料之一,其碳原子之间没有重排和错位,结构非常稳定,其C—C键长仅为0.142 nm[ 9 , 10 ]。石墨烯基复合材料具有较大的比表面积,可负载更多药物。目前,石墨烯及其衍生物在抗菌领域的研究比较全面,研究者分别从石墨烯的尺寸、表面形态及表面官能团的数量和类型等方面入手,系统地研究了石墨烯、氧化石墨烯、表面改性氧化石墨烯及石墨烯基复合材料的抗菌性能[ 11 , 12 ]。本团队在之前的研究中制备了聚乙二醇修饰的石墨烯材料,负载银纳米颗粒和磺胺嘧啶,成功制备了新型复合抗菌体系[ 13 ]。本研究拟制备聚乙二醇修饰的石墨烯材料,负载伊曲康唑得到新型抗菌体系,并对其抗腐皮镰刀菌活性进行评估。
参考文献
[1]
Brown L Leck AK Gichangi M et al. The global incidence and diagnosis of fungal keratitis[J/OL]Lancet Infect Dis 202121(3)∶e49e57[2023-03-16]http://www.ncbi.nlm.nih.gov/pubmed/33645500. DOI: 10.1016/S1473-3099(20)30448-5 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Chang HY Chodosh J Diagnostic and therapeutic considerations in fungal keratitis[J]Int Ophthalmol Clin 201151(4)∶3342. DOI: 10.1097/IIO.0b013e31822d64dc .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Vehreschild JJ Sieniawski M Reuter S et al. Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis:analysis of data from a multinational case registry[J]Int J Antimicrob Agents 200934(5)∶446450. DOI: 10.1016/j.ijantimicag.2009.06.025 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Jaiswal M Kumar M Pathak K Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis[J]Colloids Surf B Biointerfaces 20151302330. DOI: 10.1016/j.colsurfb.2015.03.059 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
卢萍梁珍张振布替萘芬纳米胶束兔眼局部点眼药代动力学研究[J]中华实验眼科杂志 202038(12)∶10381044. DOI: 10.3760/cma.j.cn115989-20200526-00374 .
返回引文位置Google Scholar
百度学术
万方数据
Lu P Liang Z Zhang Z et al. Ocular pharmacokinetics of topical administration of butenafine nanomicelles in rabbit eyes[J]Chin J Exp Ophthalmol 202038(12)∶10381044. DOI: 10.3760/cma.j.cn115989-20200526-00374 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[6]
Wilson B Geetha KM . Lipid nanoparticles in the development of mRNA vaccines for COVID-19[J/OL]J Drug Deliv Sci Technol 202274103553[2023-03-20]http://www.ncbi.nlm.nih.gov/pubmed/35783677. DOI: 10.1016/j.jddst.2022.103553 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Onugwu AL Nwagwu CS Onugwu OS et al. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases[J]J Control Release 2023354465488. DOI: 10.1016/j.jconrel.2023.01.018 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
金丽丽秦晓怡陈鹏飞温州某医院258例真菌性角膜炎诊疗分析[J]中华眼视光学与视觉科学杂志 202022(12)∶928933. DOI: 10.3760/cma.j.cn115909-20200408-00142 .
返回引文位置Google Scholar
百度学术
万方数据
Jin LL Qin XY Chen PF et al. Retrospective analysis of patients with fungal keratitis in a hospital in Wenzhou[J]Chin J Optom Ophthalmol Vis Sci 202022(12)∶928933. DOI: 10.3760/cma.j.cn115909-20200408-00142 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[9]
Zhang Y Tan YW Stormer HL et al. Experimental observation of the quantum Hall effect and Berry's phase in graphene[J]Nature 2005438(7065)∶201204. DOI: 10.1038/nature04235 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Novoselov KS Jiang Z Zhang Y et al. Room-temperature quantum Hall effect in graphene[J/OL]Science 2007315(5817)∶1379[2023-03-22]http://www.ncbi.nlm.nih.gov/pubmed/17303717. DOI: 10.1126/science.1137201 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Xin Q Shah H Nawaz A et al. Antibacterial carbon-based nanomaterials[J/OL]Adv Mater 201931(45)∶e1804838[2023-03-22]http://www.ncbi.nlm.nih.gov/pubmed/30379355. DOI: 10.1002/adma.201804838 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Karahan HE Wiraja C Xu C et al. Graphene materials in antimicrobial nanomedicine:current status and future perspectives[J/OL]Adv Healthc Mater 20187(13)∶e1701406[2023-03-22]http://www.ncbi.nlm.nih.gov/pubmed/29504283. DOI: 10.1002/adhm.201701406 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Han F Lv S Li Z et al. Triple-synergistic 2D material-based dual-delivery antibiotic platform[J/OL]NPG Asia Materials 202012(1)∶15[2023-03-26]https://www.nature.com/articles/s41427-020-0195-x.
返回引文位置Google Scholar
百度学术
万方数据
[14]
Khan F Baek SH Kim JH . One-step and controllable bipolar doping of reduced graphene oxide using TMAH as reducing agent and doping source for field effect transistors[J]Carbon 2016100608616.
返回引文位置Google Scholar
百度学术
万方数据
[15]
Hou CC Zou L Sun L et al. Single-atom iron catalysts on overhang-eave carbon cages for high-performance oxygen reduction reaction[J]Angew Chem Int Ed Engl 202059(19)∶73847389. DOI: 10.1002/anie.202002665 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Dana R A new frontier in curing corneal blindness[J]N Engl J Med 2018378(11)∶10571058. DOI: 10.1056/NEJMe1800726 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
李景果周天洋栗占荣聚合物载体对环孢素A角膜通透性的促进作用[J]中华实验眼科杂志 201836(12)∶914919. DOI: 10.3760/cma.j.issn.2095.0160.2018.12.004 .
返回引文位置Google Scholar
百度学术
万方数据
Li JG Zhou TY Li ZR et al. The facilitation of corneal permeability of cyclosporine A loaded on chitosan-graft-cyclodextrin copolymers vector[J]Chin J Exp Ophthalmol 201836(12)∶914919. DOI: 10.3760/cma.j.issn.2095.0160.2018.12.004 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[18]
Shi L Li Z Liang Z et al. A dual-functional chitosan derivative platform for fungal keratitis[J/OL]Carbohydr Polym 2022275118762[2023-03-30]http://www.ncbi.nlm.nih.gov/pubmed/34742450. DOI: 10.1016/j.carbpol.2021.118762 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Hoffman JJ Yadav R Sanyam SD et al. Topical chlorhexidine 0.2% versus topical natamycin 5% for the treatment of fungal keratitis in Nepal:a randomized controlled noninferiority trial[J]Ophthalmology 2022129(5)∶530541. DOI: 10.1016/j.ophtha.2021.12.004 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
王敬博卢萍梁珍眼用伊曲康唑固体脂质纳米粒的制备及其体外释放[J]河南医学研究 202029(6)∶972975. DOI: 10.3969/j.issn.1004-437X.2020.06.003 .
返回引文位置Google Scholar
百度学术
万方数据
Wang JB Lu P Liang Z et al. Preparation and characterization of itraconazole loaded solid lipid nanoparticel for ocular topical application and the in vitro drug release[J]Henan Med Res 202029(6)∶972975. DOI: 10.3969/j.issn.1004-437X.2020.06.003 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
备注信息
A
张俊杰,Email:mocdef.6ab2166jjgnahz
B

李景果:参与选题与研究设计、收集数据、资料分析和解释、论文撰写及修改;韩奉奇:参与选题与研究设计、收集数据、资料分析和解释;赵孟阳:参与选题与研究设计、资料分析和解释、论文修改;何继军、梁珍:参与收集数据、资料的分析和解释;张俊杰:参与选题与研究设计、论文修改及定稿

C
所有作者均声明不存在利益冲突
D
国家自然科学基金项目 (52173143)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号